Table 4

Univariate associations with clinical deterioration or need for hospital-based intervention within 5 days of PE diagnosis

Variable# with trait% with traitPrimary outcomeSevere outcome30-day mortality
% of patients without trait with outcome% of patients with trait with outcome p-Value% of patients without trait with outcome% of patients with trait with outcomep-Value% of patients without trait with outcome% of patients with trait with outcomep-Value
Age ≥65 years1173928440.0048110.321270.045
Highest HR >100 bpm1053530410.0587120.141450.641
Lowest SBP <90 mm Hg20 73175<0.001735<0.0014100.161
Highest RR >20 BrPM91 312749<0.0016150.012370.130
Lowest SaO2 <95%105352452<0.0016150.006370.084
White race2689027350.3781090.850040.236
Coronary artery disease26931620.002980.799480.322
Congestive heart failure 12433500.229980.9294170.023
Chronic lung disease481632420.2148150.1463100.014
Malignancy1073630400.086980.77019<0.001
Malignancy (active)541833370.5901040.130117<0.001
Chronic renal insufficiency8333500.3299130.7314140.164
Cerebrovascular disease20732550.0399100.880400.342
D-dimer ≥3000 mcg/mL1334530390.0887110.231450.693
Troponin-T ≥0.1 ng/mL12433500.2298250.050480.441
NT-proBNP ≥200 pg/mL128432546<0.001317<0.001260.087
PE central*1394731370.2304140.003530.340
PE multiple2036827370.1041180.546440.898
Residual DVT742529470.0058140.124450.472
Right heart strain on echocardiogram†52172863<0.001431<0.001440.962
  • Significant associations are highlighted.

  • *Central PE is defined as any clot proximal to the segmental pulmonary arteries.

  • †Right heart strain on echocardiogram includes any finding of right ventricular hypertrophy, right ventricular dilatation or bowing of the intraventricular septum towards the left ventricle.

  • BrPM, breaths per minute; DVT, deep vein thrombosis; HR, heart rate; NT-proBNP, N-terminal brain natriuretic peptide; RR, respiratory rate; SBP, systolic blood pressure; SaO2, oxygen saturation in capillary blood measured by pulse oximetry.